investors merrimackpharma.com

Investors Merrimack Pharmaceuticals

The Investor Relations website contains information about Merrimack Pharmaceuticalss business for stockholders, potential investors, and financial analysts.
traffic

OVERVIEW

This web page investors.merrimackpharma.com presently has a traffic ranking of zero (the lower the superior). We have researched seventeen pages inside the web site investors.merrimackpharma.com and found five websites referencing investors.merrimackpharma.com. I acquired three social web platforms linked to this website.
Pages Analyzed
17
Links to this site
5
Social Links
3

INVESTORS.MERRIMACKPHARMA.COM RANKINGS

This web page investors.merrimackpharma.com is seeing varying levels of traffic within the past the year.
Traffic for investors.merrimackpharma.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investors.merrimackpharma.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investors.merrimackpharma.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO BUSINESS

WHAT DOES INVESTORS.MERRIMACKPHARMA.COM LOOK LIKE?

Desktop Screenshot of investors.merrimackpharma.com Mobile Screenshot of investors.merrimackpharma.com Tablet Screenshot of investors.merrimackpharma.com

INVESTORS.MERRIMACKPHARMA.COM HOST

Our web crawlers revealed that the main page on investors.merrimackpharma.com took two hundred and ninety-three milliseconds to come up. We could not find a SSL certificate, so in conclusion our crawlers consider this site not secure.
Load time
0.293 seconds
SSL
NOT SECURE
Internet Address
23.55.218.214

BOOKMARK ICON

SERVER OPERATING SYSTEM AND ENCODING

I found that investors.merrimackpharma.com is implementing the nginx server.

TITLE

Investors Merrimack Pharmaceuticals

DESCRIPTION

The Investor Relations website contains information about Merrimack Pharmaceuticalss business for stockholders, potential investors, and financial analysts.

CONTENT

This web page states the following, "Merrimack Provides Business Update and Reports 2017 Financial Results." Our analyzers saw that the web site said " Strengthened the randomized Phase 2 SHERLOC study evaluating MM-121 in non-small cell lung cancer by expanding enrollment from 80 to 100 patients - - Dosed the first patient in randomized Phase 2 SHERBOC study evaluating MM-121 in metastatic breast cancer - - Announced the formation of a new."

SIMILAR BUSINESSES

Investor Relations - Meru Networks

Quarterly Earnings and Financial Releases. Fortinet Announces Agreement to Acquire Meru Networks. Meru Networks Q1 2015 Earnings Call.

Metals USA Investor Relations

Metals USA is a provider of processed carbon steel, stainless steel, aluminum, red metals and manufactured metal components. Reliance is the largest metal service center company in North America and a leading provider of value-added metal processing and inventory management services. Metals USA Announces Stockholder Approval Of Merger Agreement With Reliance Steel and Aluminum Co.

Investors Investors

Suite 31, Beaufort Court, Admirals Way, London E14 9XL.

Home Micro Focus Investor Relations

Micro Focus is a leading infrastructure software company with global scale. Our Strategy and Business Model. The board of Micro Focus International plc is committed to delivering outstanding shareholder returns. Trading Update, Management Change and Lender Call. Work with us, doin.

Investor Relations - Micron Technology, Inc.

China â ç ä ä æ. Japan â æ æœ èªž. Taiwan â ç é ä æ. Please enter a FBGA Code. VMWare vSAN Ready Node Solution. FBGA and Part Marking Decoder. Data is the New Currency.